i've gotten past the frustration and anger phase,
Post# of 154158
(Total Views: 588)
Posted On: 07/06/2023 8:32:43 AM
i've gotten past the frustration and anger phase, and now simply laugh at the fact that it's been 6 weeks since hearing of CA's leave - and months since hearing of the FDA's response (but nothing about our response). the only thing that bums me out at this point are the friends that i got to invest who lost money - i care a lot more about them losing money than me.
at some point it sure would be good to get some idea about where we sit and what the future looks like - and some kind of timeline. i'm not talking just about when the hold may be lifted or when we might start a trial, etc. I mean - what is the realistic timeline to when we may either have data that a buyer can use - or that we may have actual revenue. Unless I'm wrong - we won't even start a true NASH trial until later this year - and that will take a long time (1-2 years) to enroll, complete the trial, get usable data, etc. That's not a pessimistic view - i think just realistic - trials take a really long time, even if things go smoothly.
Clearly we can see the share price go up based on a partnership, etc., and that would be great - but I'd also like a sober assessment of where the timing is on these major milestones (1. having real, irrefutable clinical data that a buyer can interpret and use to make a decision, and 2. generating revenue) would be incredibly refreshing, and i think we deserve it at this point after living through this investment.
But as I said, i've transitioned to the "whatever happens, happens" attitude about this investment - and don't worry about worst case (or plan my future on best case) - because none of us knows at this point.
Hopefully we hear something in the next couple of weeks about a call - and I'll put those 2 questions in the que.
at some point it sure would be good to get some idea about where we sit and what the future looks like - and some kind of timeline. i'm not talking just about when the hold may be lifted or when we might start a trial, etc. I mean - what is the realistic timeline to when we may either have data that a buyer can use - or that we may have actual revenue. Unless I'm wrong - we won't even start a true NASH trial until later this year - and that will take a long time (1-2 years) to enroll, complete the trial, get usable data, etc. That's not a pessimistic view - i think just realistic - trials take a really long time, even if things go smoothly.
Clearly we can see the share price go up based on a partnership, etc., and that would be great - but I'd also like a sober assessment of where the timing is on these major milestones (1. having real, irrefutable clinical data that a buyer can interpret and use to make a decision, and 2. generating revenue) would be incredibly refreshing, and i think we deserve it at this point after living through this investment.
But as I said, i've transitioned to the "whatever happens, happens" attitude about this investment - and don't worry about worst case (or plan my future on best case) - because none of us knows at this point.
Hopefully we hear something in the next couple of weeks about a call - and I'll put those 2 questions in the que.
(12)
(0)